Effect of dexamethasone on immunoreactive corticotropin-releasing factor in the rat median eminence and intermediate-posterior pituitary

T SUDA, N TOMORI, F TOZAWA, T MOURI… - …, 1984 - academic.oup.com
T SUDA, N TOMORI, F TOZAWA, T MOURI, H DEMURA, K SHIZUME
Endocrinology, 1984academic.oup.com
Abstract Immunoreactive ACTH (I-ACTH) concentrations in the anterior pituitary,
intermediate-posterior pituitary (IP), and plasma and immunoreactive corticotropin-releasing
factor (I-CRF) concentrations in the median eminence and IP were determined in rats
receiving dexamethasone for various periods from 16 h to 10 days. Plasma I-ACTH
concentrations were decreased 16 h after a single injection of dexamethasone. Anterior
pituitary I-ACTH concentrations did not decrease until 4 days after the start of …
Abstract
Immunoreactive ACTH (I-ACTH) concentrations in the anterior pituitary, intermediate-posterior pituitary (IP), and plasma and immunoreactive corticotropin-releasing factor (I-CRF) concentrations in the median eminence and IP were determined in rats receiving dexamethasone for various periods from 16 h to 10 days. Plasma I-ACTH concentrations were decreased 16 h after a single injection of dexamethasone. Anterior pituitary I-ACTH concentrations did not decrease until 4 days after the start of dexamethasone medication. IP I-ACTH concentrations did not change throughout these periods. I-CRF concentrations in median eminence and IP rapidly decreased after dexamethasone administration. These results raise the possibility that the source of I-CRF in the IP is hypothalamic. (Endocrinology114: 851, 1984)
Oxford University Press